{"symbol":"BMY","fiscalQuarter":"Q2-2024","reportDate":"2024-07-26","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q2-2024","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Up 11.44%","keyNumbers":[{"metric":"EPS","actual":"$2.07","expected":"N/A","surprise":"+26.53%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported a strong earnings per share, exceeding expectations significantly. The stock reacted positively, rising by 11.44%, likely driven by investor confidence in the company's performance despite the lack of revenue data and management commentary.","metaDescription":"Bristol-Myers Squibb (BMY) Q2 2024 earnings: EPS beat by 26.53%. Stock up 11.44%. Full breakdown."}}